TOPELIA THERAPEUTICS

Serial Number 90505371
Registration 7414142
700

Registration Progress

Application Filed
Feb 2, 2021
Under Examination
May 31, 2022
Approved for Publication
Apr 5, 2022
Published for Opposition
Apr 5, 2022
Registered
Jun 11, 2024

Trademark Image

TOPELIA THERAPEUTICS

Basic Information

Serial Number
90505371
Registration Number
7414142
Filing Date
February 2, 2021
Registration Date
June 11, 2024
Published for Opposition
April 5, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 11, 2024
Registration
Registered
Classes
005

Rights Holder

Progenabiome, LLC

16
Address
1835 Knoll Drive
Ventura, CA 93003

Ownership History

Progenabiome, LLC

Original Applicant
16
Ventura, CA

Progenabiome, LLC

Owner at Publication
16
Ventura, CA

Progenabiome, LLC

Original Registrant
16
Ventura, CA

Legal Representation

Attorney
Daniel M. Cislo, Esq.

USPTO Deadlines

Next Deadline
1596 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240611)
Due Date
June 11, 2030
Grace Period Ends
December 11, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description Documents
Jun 11, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jun 11, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
May 7, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
May 7, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
May 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 6, 2024 ALIE A ASSIGNED TO LIE Loading...
Dec 15, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 8, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Sep 8, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jun 17, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 17, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jun 17, 2023 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Jun 14, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
May 16, 2023 IUAF S USE AMENDMENT FILED Loading...
Jun 7, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
May 16, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 30, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 30, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 30, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
May 31, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 5, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 5, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 28, 2022 ALIE A ASSIGNED TO LIE Loading...
Feb 25, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 24, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 23, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 23, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 2, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 2, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 2, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 30, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 6, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 5, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of COVID 19, Corona viruses, Influenza, Autism, Alzheimer's, Parkinson's Disease, Multiple Sclerosis, and Epstein-Barr Virus
First Use Anywhere: Jan 31, 2021
First Use in Commerce: Jan 31, 2021

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"